The Hindu Business Line : GlaxoSmithKline contests patent plea rejection before HC

GLAXOSMITHKLINE plc, the pharmaceuticals major, on Wednesday moved an application before Mr Justice Pinaki Chandra Ghose of the Calcutta High Court, contesting the refusal of a patent application by the office of the Controller of Patents & Designs sometime ago.

The company had applied to the Controller for a patent on a pharmaceutical product, Rosiglitazone Maleate tablet and a solvent under the provisions of the P&D Act. After considering the application, the Controller rejected the application of Glaxo, which had sought a patent for the product, which was claimed to be a researched and invented one. The Controller, however, refused to accept this as the same is already in the markets of the US and Brazil, having been patented thereof. The product is a conventional one and not invented, the Controller had pointed out. Glaxo, in its application today, submitted before the court that the order of the Controller refusing grant of patent was illegal.

More Stories on : IPR | Courts/Legal Issues | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Merz Pharma to launch drug for Alzheimer's dementia

BHEL to pay 35 pc interim

Lodha caveat: Hearing on Tapuria plea begins

Ranbaxy gets FDA nod for anti-depressant

Haldia Petrochemicals IPO likely in Feb

Ministry to notify panel accounting norms by March 31

Britannia management gets a facelift

GlaxoSmithKline contests patent plea rejection before HC

IOC to buy 50% stake in Iranian gas block

Sun Pharma looking at acquisition in US

Sundram Fasteners to set up tool room, machining facility

CCEA clears Rs 1,000-cr package for ITI

Bestavision fails to get shelter under BIFR

Spat may hit Reliance's strategic direction: S&P